Pharma
The company also announced a partnership with pharma giant Biogen that allows providers to submit enrollment forms for its multiple sclerosis drug Vumerity through the new platform.
Dr. Oliver Bleck, area head of Europe South at Roche, describes the pharma giant's work in personalized medicine.
The collaboration aims to lower the cost of prescription drugs for Capital Blue Cross members.
The alliance will expand Sanofi's trek into tech-based drug discovery and development platforms.
Mati Gil, CEO of AION Labs, describes how its new startup OMEC.AI came to fruition and what it aims to accomplish for drug discovery and development.
nference said researchers can use the de-identified clinical data to develop new therapeutics and diagnostics.
Smart stethoscope company Eko received a $2.7 million grant from the National Institutes of Health, and Halo raised $2.6 million for its research and development collaboration tool.
The company announced a $200 million Series C round in January.
Also, scientists from the University of South Australia have developed tiny fibre sensors for remote patient monitoring.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.